ProfileGDS4132 / 239638_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 83% 83% 83% 86% 86% 85% 84% 71% 88% 88% 94% 92% 86% 80% 95% 95% 93% 89% 91% 92% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101300.04183
GSM201543Muscle PCOS pioglitazone 121280.1483
GSM201544Muscle PCOS pioglitazone 161318.11883
GSM201545Muscle PCOS pioglitazone 201382.66886
GSM201829Muscle PCOS pioglitazone 231359.67286
GSM201830Muscle PCOS pioglitazon 251333.6385
GSM201831Muscle PCOS pioglitazone 271319.03684
GSM201832Muscle PCOS pioglitazone 31205.07871
GSM201833Muscle PCOS pioglitazone 41372.62188
GSM201834Muscle PCOS pioglitazone 81410.87688
GSM201835Muscle PCOS after pioglitazone 102637.96694
GSM201836Muscle PCOS after pioglitazone 122521.28792
GSM201837Muscle PCOS after pioglitazone 162334.87386
GSM201838Muscle PCOS after pioglitazone 202280.8580
GSM201839Muscle PCOS after pioglitazone 232719.12595
GSM201840Muscle PCOS after pioglitazone 252792.17495
GSM201841Muscle PCOS after pioglitazone 272594.87893
GSM201842Muscle PCOS after pioglitazone 32399.26589
GSM201843Muscle PCOS after pioglitazone 42494.14691
GSM201844Muscle PCOS after pioglitazone 82525.33792